A new tool provides a personalised risk score for developing breast cancer, and can reduce unnecessary investigations.
A new study suggests that artificial intelligence, also known as AI, may offer a better solution. Scientists have developed a ...
10d
Science for living: Can using AI risk prediction in breast cancer screening improve early detection?
Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...
n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...
Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict five-year breast cancer risk from a routine screening mammogram. According to ...
CLAIRITY BREAST provides clinicians with a first-in-class, novel platform for identifying future risk of breast cancer CLAIRITY BREAST analyzes subtle imaging features on screening mammograms that ...
Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, ...
Scientists have developed an AI system that analyzes complex gene-expression signatures to estimate the likelihood that a tumor will spread.
An image-only artificial intelligence (AI) model for predicting the five-year risk of breast cancer provided stronger and more precise risk stratification than breast density assessment, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results